Calcified tissue international
-
Calcif. Tissue Int. · Sep 2000
Measurement of bone density around total knee arthroplasty using fan-beam dual energy X-ray absorptiometry.
The clinical survival of joint arthroplasties is clearly associated with the quality of surrounding bone environment. Bone mineral density (BMD) is an important measure of bone strength and quality. Periprosthetic BMD can be measured by using dual-energy X-ray absorptiometry (DXA) with special software algorithms. ⋯ In the prosthesis-free control knees, CV% were similar; 3.2% and 2.5%, respectively. The best precision was found in the femoral diaphyses above the implant (1.3%), whereas the least reproducible BMD was determined in the patellar region of the TKA knees (6.9%). Our results confirm that DXA measures precisely small bone mineral changes around TKA and makes it possible to follow bone remodeling DXA and may provide a feasible method for monitoring TKA in the future.
-
Calcif. Tissue Int. · Aug 2000
Comparative StudyTotal body and regional bone mineral densitometry (BMD) and soft tissue measurements: correlations of BMD parameter to lumbar spine and hip.
Bone loss in men and women seems to differ according to the skeletal regions or particular areas being evaluated. Dual energy X-ray absorptiometry (DXA) is the method of choice for measuring total body and regional bone mineral area density (BMD). The aim of the study was to evaluate the importance of DXA measurements of total body in relation to lumbar spine and hip in different scan beam designs. ⋯ There were also highly significant correlations between the lumbar spine (or hip) and total body, being best for the subregional thorax. Our data demonstrate short-and mid-term precision errors of BMD with reproducible results for most areas in SB and FB design, whereas soft tissue measurements vary depending on the area being measured. Furthermore, there is a close relationship between BMD values of total body total and subregional parameters and lumbar spine and hip scans, respectively.
-
Vitamin D, a modulator of macrophage function, can activate human anti-mycobacterial activity. Vitamin D deficiency is therefore associated with a higher risk of tuberculosis (TB) infection, as indicated by several observations. ⋯ Third, the incidence of TB is higher among subjects with relatively low serum vitamin D levels, such as the elderly, uremic patients, and Asian immigrants in the U. K.
-
Calcif. Tissue Int. · Jan 2000
Comparative StudyRestoration of ovariectomy-induced osteopenia by nitroglycerin.
Nitric oxide (NO) is known to inhibit osteoclastic bone resorption. Previously, we demonstrated that the NO donor nitroglycerin (NG) prevented ovariectomy (OVX)-induced bone loss. The current study shows that NG restores ovariectomy-induced osteopenia. ⋯ The increased urinary excretion of deoxypyridinolines caused by OVX was negated by estrogen, NG, and estrogen together with NG (P < 0.01). In contrast to estrogen, NG did not decrease the post-OVX-induced increase of serum osteocalcin levels, suggesting that NG may also have a positive effect on bone formation. In summary, the results suggest that the NO donor, NG, reverses the OVX-induced bone loss in rats, and these effects are likely due to decreased bone resorption and, perhaps, increased bone formation.
-
Calcif. Tissue Int. · Jul 1999
Randomized Controlled Trial Multicenter Study Comparative Study Clinical TrialEarly postmenopausal bone loss is prevented by estrogen and partially by 1alpha-OH-vitamin D3: therapeutic effects of estrogen and/or 1alpha-OH-vitamin D3.
A total of 79 Japanese women who were within 5 years of menopause were randomly assigned 1alpha-hydroxyvitamin D3 [1alpha(OH)D3] 1.0 microg/day, conjugated estrogens 0.625 mg/day, a combination of both, or control (no treatment). Lumbar spine and proximal femur bone mineral density (BMD) and biochemical indices were monitored over 2 years. In the 1alpha(OH)D3-treated group, there was a nonsignificant decrease in lumbar spine BMD compared with controls, and no significant loss in the femoral neck compared with controls. ⋯ The results of this study indicate that early postmenopausal bone loss in the femoral neck is prevented by conjugated estrogens, 1alpha(OH)D3, or both, whereas bone loss in the spine is not prevented by 1alpha(OH)D3. Estrogen proves effective in preventing early postmenopausal bone loss by markedly inhibiting bone turnover. Moreover, a synergistic bone-sparing effect can be expected when estrogen is administered concomitantly with 1alpha(OH)D3 rather than when used alone.